youtube_live
Q3 2026 daromadi • 5 kundan keyin
Tafsilotlarchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,93 US$
arrow_downward
-0,68%(-0,020) 1K
2,93 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 29-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,94 US$
Yuqori
2,98 US$
Past
2,86 US$
Bozor kapitali
449,99 mln
Oʻrtacha hajm
2,98 mln
Hajmi
3,22 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,94 US$
Yuqori
2,98 US$
Past
2,86 US$
Bozor kapitali
449,99 mln
Oʻrtacha hajm
2,98 mln
Hajmi
3,22 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida